Yes, HRT mood swings are real, and they can show up before you start treatment, while your dose is being settled, or when a hormone level dips between doses. Most of the time they trace back to the hormone transition itself or to a regimen that needs adjusting, and a clinician can usually work through…
Yes, HRT mood swings are real, and they can show up before you start treatment, while your dose is being settled, or when a hormone level dips between doses. Most of the time they trace back to the hormone transition itself or to a regimen that needs adjusting, and a clinician can usually work through it with you. This article is about menopausal hormone replacement therapy (HRT) for women, prescribed after medical evaluation. It is not about gender-affirming care, and nothing here replaces a diagnosis or an exam.
If you are a current or prospective patient, you can request an appointment to review your symptoms.
Estrogen and progesterone act on the brain as well as the reproductive system, so shifts in either can be felt as changes in mood, sleep, and stress tolerance. That is why perimenopause mood swings are so common: hormone levels rise and fall unevenly during the years before menopause, and mood can swing with them.
Research supports the idea that the change matters, not just the level. In a study published in JAMA Psychiatry by Schmidt and colleagues at the National Institute of Mental Health, women with a history of perimenopausal depression who were switched from estradiol to placebo had a significant rise in depressive symptoms, with average scores climbing from 2.4 to 8.8 (Schmidt et al., 2015). The study was small (56 women), so it shows that a hormone change can drive mood symptoms, not that it will for everyone.
A literature review of population-based studies, including the SWAN cohort, adds context. It found depressive symptoms were more common in the early and late menopause transition than before it (odds ratios of 1.30 and 1.71), that a history of depression was the strongest predictor, and that the contribution of measured hormones was small (review in PMC). In other words, hormones are one piece of a larger picture. You can read more about how therapy fits into care after 40 in our guide to hormone replacement therapy for women.
Too little hormone may leave the transition symptoms in place, while too much can bring its own side effects. Pills, patches, gels, and creams deliver hormones differently, and finding the right combination often takes some adjustment. Your prescriber makes those changes; you should not.
A patch that loosens, a missed dose, or an uneven schedule can make hormone levels bounce, and mood may follow. Tell your prescriber if symptoms cluster at the end of a dosing cycle.
Women who still have a uterus are usually prescribed a progestogen alongside estrogen. Some women notice mood changes with certain progestogens or schedules. This is worth raising, because a different type or timing can sometimes help.
Therapy does not freeze the menopause transition. Your own hormone output may still be fluctuating underneath the treatment.
Night sweats and broken sleep erode mood on their own. Midlife also tends to stack responsibilities, and stress amplifies every other cause on this list.
Thyroid problems, depression, and anxiety disorders can look like hormone-related mood swings. Labs and a clinical conversation help sort them out. Our overview of hormone optimization explains how testing and monitoring work at Cardiomender Weight Loss & Aesthetics, and our post on signs of a hormone imbalance describes symptoms that can overlap.
There is no single, well-established timeline that applies to everyone. Some women feel steadier within weeks of a regimen that suits them, some need several adjustments, and some find that mood symptoms had another cause that HRT does not treat. You may see online claims that mood settles in a fixed number of months; we could not confirm a clinical-grade source for a specific figure, so we are not offering one.
What is well supported is the pattern that a hormone change can trigger symptoms, as in the NIMH study above, and that individual responses vary. The practical answer is to agree on a reassessment point with your prescriber when you start, and to call sooner if symptoms are severe or worsening. If mood swings persist through a dose adjustment or two, that is useful information: it may point to another cause.
The evidence is encouraging but modest, and it is important to read it honestly.
| Study | Who | Result |
|---|---|---|
| Soares et al., Archives of General Psychiatry, 2001 | 50 perimenopausal women aged 40-55 with depressive disorders | After 12 weeks of transdermal estradiol (100 µg) versus placebo, remission was 68% versus 20% (P=.001) |
| Li et al., Journal of Affective Disorders, 2026 (meta-analysis) | 12 randomized trials | Small reduction in depressive symptoms versus placebo (SMD -0.23; 95% CI -0.43 to -0.03); no clear difference by route; adverse events mild to moderate; limited certainty |
| World Journal of Psychiatry editorial, 2024 | Discussion of one trial of estrogen-progesterone therapy | Reported effectiveness of 96.05% versus 86.84% (P=0.042); an editorial about a single trial, so treat with caution |
The Soares trial enrolled women who had depressive disorders during perimenopause, so it does not show that HRT will lift mood in every woman. The larger meta-analysis found a much smaller average effect. The Menopause Society (formerly NAMS) position statement on hormone therapy notes that estrogen therapy may have antidepressant effects in perimenopausal women, that it is not effective for depressive disorders in postmenopausal women, and that hormone therapy is not a first-line treatment for major depression or anxiety (2022 position statement).
Taken together: HRT may help some women’s mood symptoms, particularly in perimenopause, but it should not be counted on as a treatment for a mood disorder.
Some women report HRT anxiety during the first weeks, and others find that anxiety eased once therapy was adjusted. Feeling on edge because of poor sleep and fluctuating hormones is different from an anxiety disorder, which involves persistent, disruptive worry. The Menopause Society statement above says hormone therapy is not first-line for anxiety disorders. If anxiety is constant or interferes with daily life, ask for a mental health evaluation in addition to a hormone review.
Menopause mood swings treatment works best as a combination: a clinician-guided hormone plan plus daily habits that steady your baseline.
Ask whether dose, route, timing, or progestogen could be contributing. Never self-adjust. HRT always requires medical evaluation, diagnosis, and ongoing supervision.
Bring these items to your visit:
Keep a regular bedtime, keep the bedroom cool, and tell your prescriber if night sweats are waking you.
Regular activity is a general health habit that many women find helps with stress and sleep. Our guide to exercise gives practical starting points.
Regular meals help avoid energy crashes that can feel like mood dips. See our page on nutrition for ideas, and consider cutting back on alcohol and caffeine if they seem to make symptoms worse.
Talking with a counselor can help with stress and low mood, and it pairs well with medical care. Our support resources describe the coaching and follow-up we offer.
Some women cannot or prefer not to use hormone therapy. Non-hormonal options exist for mood and sleep, and a clinician can discuss which ones suit your history.
HRT side effects vary by person, product, and dose. Commonly reported effects of menopausal hormone therapy include breast tenderness, bloating, headaches, nausea, and irregular bleeding, and some women report mood changes. Meta-analysis data describe adverse events as mild to moderate, though certainty is limited. Tell your prescriber about any side effect, especially unexpected vaginal bleeding, severe headaches, leg swelling or pain, or chest pain. Individual responses vary, and no outcome can be promised.
HRT is not appropriate for everyone. Your history, including cardiovascular risk, clotting history, hormone-sensitive cancers, and unexplained bleeding, has to be reviewed by a clinician before treatment begins. Generally, therapy is considered for women who are recently menopausal and at low risk, and it should be reviewed regularly.
Regarding FDA scope: approval applies to specific products for specific indications, and we do not present HRT as an approved treatment for mood disorders. If you want to know what applies to a particular product and your situation, your prescriber can tell you. You can read about the local service on our HRT for women in Pembroke Pines page, and our disclaimers explain how we handle medical information.
Call your prescriber if:
Get urgent help now if you have thoughts of harming yourself or ending your life. Call or text 988 to reach the 988 Suicide & Crisis Lifeline, which is available 24/7 and is free and confidential, or call 911 in an emergency.
Cardiomender Weight Loss & Aesthetics has provided medically supervised care in Pembroke Pines since 2009, so mood concerns are handled in person rather than through a prescription and a phone call. Patients typically get lab work, a review of medical history, a plan built around their goals, and scheduled follow-up so that dose and regimen questions get answered early. You can learn about our approach, meet our team, read about us, or see what others say in patient reviews. Our hours are posted online, and CardioMender answers common questions on the FAQ page.
It can happen. Hormone levels change when therapy starts or when the dose is adjusted, and a change in estrogen has been linked to mood symptoms in research. If you feel worse, call your prescriber rather than stopping on your own.
It varies. We could not confirm a reliable clinical timeline, so your prescriber should set a reassessment point with you and adjust the plan if you are not improving.
Some women report anxiety on hormone therapy, especially early on or when levels swing. Tell your prescriber, because dose and timing can be reviewed. Persistent anxiety may need a separate evaluation.
Do not stop without talking to your prescriber. In one study, women switched abruptly from estradiol to placebo had a rise in depressive symptoms, so changes are best planned with a clinician.
Breast tenderness, bloating, headaches, and nausea are commonly reported effects. Because these overlap with other causes, your prescriber should decide whether the dose needs changing.
The meta-analysis found no clear difference by route for depressive symptoms. Still, a route that gives steadier levels for you may feel better, which is a conversation for your prescriber.
No. The Menopause Society says hormone therapy is not first-line for major depression or anxiety. Some perimenopausal women may see mood benefits, but depression needs its own evaluation.
That depends on your medical history and the specific medicines, so it should be decided by your prescriber, who can review everything you take.
Serving patients from across South Florida at our Pembroke Pines, FL clinic. If mood changes are affecting your daily life, contact CardioMender or call (954) 799-6439 to schedule an evaluation with our medical team.
Our physician-supervised weight loss and aesthetic programs are designed around your unique body, goals, and lifestyle.
